Author

Daniel Ceballos 1

1 Hospital Dr. Negrin

APPRECIA: ADALIMUMAB VS AZATHIOPRINE IN THE PREVENTION OF CROHN’S DISEASE RECURRENCE AFTER SURGICAL RESECTION. A GETECCU MULTICENTER RANDOMIZED TRIAL.

Antonio López San Román, Isabel Vera Mendoza, Eugeni Domenech Morral, Carlos Taxonera, Vicente Vega, Ignacio Marín-Jiménez, Jordi Guardiola Capon, Luisa Castro, Maria Esteve Comas, Valle García, Daniel Ceballos, Pilar Martínez-Montiel, Javier Gisbert, Miguel Mínguez, Ana Echarri Piudo, Xavier Calvet Calvo, Jesús Barrio, Jo

CHANGES IN RESOURCE UTILISATION IN PATIENTS WITH CROHN'S DISEASE TREATED WITH ADALIMUMAB IN ROUTINE CLINICAL PRACTICE

Cristobal de la Coba, Daniel Ceballos, Jose Fernando Muñoz Nuñez, Jose Fernando Muñoz Nuñez, M. Dolores Aguilar, Pablo Lázaro

CLINICAL RESPONSE, QUALITY OF LIFE AND WORK ACTIVITY IN PATIENTS WITH CROHN'S DISEASE TREATED WITH ADALIMUMAB IN ROUTINE CLINICAL PRACTICE.

Jose Fernando Muñoz Nuñez, Jose Fernando Muñoz Nuñez, Daniel Ceballos, Cristobal de la Coba, M. Dolores Aguilar, Pablo Lázaro

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB THERAPY FOR COMPLEX PERIANAL FISTULA IN CROHN’S DISEASE: THE HEAL STUDY

María José Casanova, María Chaparro Sanchez, Berta Caballol, María José García, Francisco Mesonero, Cristina Rubín de Célix, Patricia Suárez Álvarez, Rocío Ferreiro-Iglesias, María del Mar Martín-Rodríguez, Ruth María de Francisco García, Pilar Varela Trastoy, Guillermo Bastida, Marta Carrillo Palau, Andrea Núñez-Ortiz, Patri

EFFICACY AND SAFETY OF USTEKINUMAB USING ENDOVENOUS INDUCTION IN CROHN´S DISEASE: REAL-WORLD CLINICAL SETTING FROM A MULTICENTER OBSERVATIONAL STUDY

Alejandro Hernandez Camba, Laura Ramos, Marta Carrillo Palau, G. Esther Rodriguez, Andres Figueroa, Inmaculada Alonso, Carlos Tardillo, Monica Peñate, Milagros Vela, Daniel Ceballos, Laura Arranz, Yolanda Rodríguez, Noelia Cruz, Sergio Amat, Lilyan Kolle, Enrique Quintero

Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Maria Chaparro Sanchez, Manuel Barreiro-de Acosta, JOSE MANUEL BENITEZ CANTERO, Jose Luis Cabriada, María José Casanova, Daniel Ceballos, María Esteve, Hipólito Fernández, Daniel Ginard, Fernando Gomollon, Rufo H. Lorente, Pilar Nos, Sabino Riestra, Montserrat Rivero, Pilar Robledo, Cristina Rodriguez, Beatriz Sicilia, Emi

EPIDEMIOLOGY, DIAGNOSTIC WORK-UP AND PHARMACOLOGICAL TREATMENTS OF INFLAMMATORY BOWEL DISEASE IN SPAIN: RESULTS FROM THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU

Maria Chaparro Sanchez, Manuel Barreiro de-Acosta, Jose Manuel Benitez, Jose Luis Cabriada Nuño, María José Casanova González, Daniel Ceballos, Maria Esteve Comas, Hipolito Fernández Rosáenz, Daniel Ginard Vicens, Fernando Gomollón Garcia, Rufo Lorente Poyatos, Pilar Nos Mateu, Sabino Riestra Menéndez, Montserrat Rivero, Pila

SURGICAL AND HOSPITAL ADMISSION IN ADULTS NEWLY DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE IN THE BIOLOGICAL ERA IN SPAIN: RESULTS OF THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU

Maria Chaparro Sanchez, Manuel Barreiro de-Acosta, Jose Manuel Benitez, Jose Luis Cabriada, María José Casanova, Daniel Ceballos, Maria Esteve Comas, Hipolito Fernández Rosáenz, Daniel Ginard Vicens, Fernando Gomollón, Rufo Lorente Poyatos, Pilar Nos, Sabino Riestra Menéndez, Montserrat Rivero, Pilar Robledo, Cristina Rodrig

URINARY METABOLOME IN NEWLY DIAGNOSED TREATMENT-NAÏVE CROHN’S DISEASE PATIENTS: RESULTS FROM THE IBDOMICS STUDY

Rubén Gil-Redondo, Nieves Embade, Sabino Riestra, Montserrat Rivero, Ana Gutiérrez, Iago Rodríguez, Luis Fernández, Daniel Ceballos, Jose Manuel Benitez, Mariam Aguas, Iria Bastón-Rey, Alicia Algaba, María José Casanova, Rufo H. Lorente, Yolanda Ber, Vanesa Royo, María Esteve, Oscar Millet, Javier Gisbert, Maria Chaparro

Item 1 - 9 / 10
1